ARCHIVES

Targeting One Specific Protein Can Double PFS; Triple Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Signet Cell A Rising Trend In Patients Under Age 40

November 25, 2011

Top 42 CCOPs (According To Priority Scores) Identified; Present Budget Would Draw Payline At 230

April 3, 1987

Nixon Resignation Won’t Hurt Cancer Program, Might Lead To More Money; Weinberger Stays

August 16, 1974

Archival photos: Senator Ernest “Fritz” Hollings, namesake of MUSC Hollings Cancer Center

February 2, 2021

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002